Essa Pharma Inc Expected To Post A Loss Of 26 Cents A Share: Earnings Preview

ESSA Pharma

02/08/2021 23:41

* ESSA Pharma Inc  EPIX.OQ   EPIX.O  is expected to show a no
change in quarterly revenue when it reports results on August 4
(estimated). 
​* Refinitiv's mean analyst estimate for ESSA Pharma Inc is for
a loss of 26 cents per share. For the same quarter last year,
the company reported a loss of 24 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for ESSA Pharma Inc
is $42​, about 46.3% above​ its last closing price
of $22.56. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.21       -0.21      -0.36     Missed  -68.2
 Dec. 31 2020  -0.17       -0.17      -0.20     Missed  -17.6
 Sep. 30 2020  -0.20       -0.19      -0.13     Beat    33.3​
 Jun. 30 2020  -0.29       -0.29      -0.24     Beat    18.2
 Mar.          -0.22​      -0.22      -0.45     Missed  -104.5
 31​ 2020​                                              ​
 Dec. 31 2019  -0.17       -0.17      -0.22     Missed  -25.7​
 Sep. 30 2019  -0.11       -0.17      -0.23     Missed  -35.3
 Jun. 30 2019  -0.54       -0.54      -0.52     Beat    3.7
 This summary was machine generated August 2 at 22:41 GMT.  All
figures in US dollars unless otherwise stated